ADA Scientific Sessions 2026 Abstract

A Long-Acting Quintuple Agonist for the GLP-1, GIP, Glucagon, Amylin, and Calcitonin Receptors Induces Greater Weight Loss than Retatrutide in Obese Rats

By Jonathan Douros, Stephanie A. Mowery, Michael Kalwat, Patrick J. Knerr

Experiments in animalsInterventions

The paper

Jonathan Douros, Stephanie A. Mowery, Michael Kalwat, Patrick J. Knerr

Indianapolis

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 2839-LB

doi.org/10.2337/db26-2839-lb

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice